Acadia Pharmaceuticals: Deutsche Bank cuts target price to $30 from $31
ACAD•Deutsche Bank cut its target price for Acadia Pharmaceuticals to $30 from $31.
Related News
Kura Oncology grants options for 55,500 shares to three new employees
KURA•
Truist Securities cuts MACOM Technology Solutions target price to $310 from $375
MTSI•
FIS: Argus Research cuts to hold from buy
FIS•
Cummins: Truist Securities cuts target price to $637 from $779
CMI•
Sabesp debt rises R$ 6.3 billion to R$ 46.44 billion at end-September
SBS•